LOCALIZATION OF B-CELL STIMULATORY ACTIVITY OF HIV-1 TO THE CARBOXYL TERMINUS OF GP41

被引:40
作者
CHIRMULE, N
KALYANARAMAN, VS
SAXINGER, C
WONGSTAAL, F
GHRAYEB, J
PAHWA, S
机构
[1] CORNELL UNIV,N SHORE UNIV HOSP,COLL MED,DEPT PEDIAT,300 COMMUNITY DR,MANHASSET,NY 11030
[2] BIONET RES LABS INC,ROCKVILLE,MD
[3] CENTECOR,MALVERN,PA
[4] NCI,BETHESDA,MD 20205
关键词
D O I
10.1089/aid.1990.6.299
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Patients with AIDS are known to have B-cell hyperactivity. We have previously demonstrated that an extract of HIV-1 could induce differentiation of peripheral blood B lymphocytes of healthy volunteers into immunoglobulin-secreting cells. In an attempt to delineate the B-cell stimulatory subregion in HIV-1, we have investigated the influences of native glycoproteins and recombinant proteins of the envelope. The complete envelope glycoprotein, gpl60 and a recombinant protein in the carboxyl terminal region of gp41 termed PE-8 were effective in inducing terminal differentiation of normal peripheral blood B lymphocytes and did so in a T-lymphocyte-dependent manner. The activity was not present in the native exterior envelope glycoprotein, gpl20 and several other recombinant proteins, viz PE-2 an PE-3, which are in the amino terminal region of gpl20 or in env-9, a protein in the junctional region of gpl20 and gp41. Polyclonal and monoclonal antibodies directed to diverse regions of the envelope abrogated the influence of gpl60. The PE-8-induced B-cell differentiation was abrogated by goat anti-gpl60 antibody but not by goat anti-gpl20 antibody or monoclonal antibody to the amino terminal of gp41. These studies suggest that a putative polyclonal B-cell stimulatory epitope of HIV-1 is located in the carboxyl end of the envelope glycoprotein. © 1990, Mary Ann Liebert, Inc. All rights reserved.
引用
收藏
页码:299 / 305
页数:7
相关论文
共 27 条
  • [1] SPONTANEOUS INVITRO PRODUCTION OF VIRUS-SPECIFIC ANTIBODY BY LYMPHOCYTES FROM HIV-INFECTED SUBJECTS
    AMADORI, A
    DEROSSI, A
    FAULKNERVALLE, GP
    CHIECOBIANCHI, L
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 46 (03): : 342 - 351
  • [2] ANTIGENIC PEPTIDES RECOGNIZED BY LYMPHOCYTES-T FROM AIDS VIRAL ENVELOPE-IMMUNE HUMANS
    BERZOFSKY, JA
    BENSUSSAN, A
    CEASE, KB
    BOURGE, JF
    CHEYNIER, R
    LURHUMA, Z
    SALAUN, JJ
    GALLO, RC
    SHEARER, GM
    ZAGURY, D
    [J]. NATURE, 1988, 334 (6184) : 706 - 708
  • [3] CHIRMULE N, 1988, J ACQ IMMUN DEF SYND, V1, P425
  • [4] FAUCI A, 1988, CLIN RES, V35, P503
  • [5] HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III (HTLV-III) CORE ANTIGENS - SYNTHESIS IN ESCHERICHIA-COLI AND IMMUNOREACTIVITY WITH HUMAN-SERA
    GHRAYEB, J
    KATO, I
    MCKINNEY, S
    HUANG, JJ
    CHANDA, PK
    HO, DD
    SARANGADHARAN, MG
    CHANG, TW
    CHANG, NT
    [J]. DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1986, 5 (02): : 93 - 99
  • [6] GOLDSTEIN H, 1985, J IMMUNOL, V135, P339
  • [7] 2ND CONSERVED DOMAIN OF GP120 IS IMPORTANT FOR HIV INFECTIVITY AND ANTIBODY NEUTRALIZATION
    HO, DD
    KAPLAN, JC
    RACKAUSKAS, IE
    GURNEY, ME
    [J]. SCIENCE, 1988, 239 (4843) : 1021 - 1023
  • [8] JANOSSY G, 1975, TRANSPLANT REV, V24, P12
  • [9] A UNIQUE HUMAN IMMUNODEFICIENCY VIRUS CULTURE SECRETING SOLUBLE GP160
    KALYANARAMAN, VS
    PAL, R
    GALLO, RC
    SARNGADHARAN, MG
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1988, 4 (05) : 319 - 329
  • [10] KROWKA J, 1988, Clinical and Experimental Immunology, V72, P179